Crumly & Associates Inc. Pfizer Inc Transaction History

Crumly & Associates Inc.

$295 Million
Q1 2025

A detailed history of Crumly & Associates Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Crumly & Associates Inc. holds 16,111 shares of PFE stock, worth $391,497. This represents 0.14% of its overall portfolio holdings.

Number of Shares

16,111

Previous 12,722 26.64%

Holding current value

$391,497

Previous $337,000 21.07%

% of portfolio

0.14%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	BUY	$25.01 - $27.13 $84,758 - $91,943	3,389 Added 26.64%	16,111 $408,000
Q4 2024 Feb 03, 2025	BUY	$24.8 - $30.19 $48,161 - $58,628	1,942 Added 18.01%	12,722 $337,000
Q3 2024 Nov 01, 2024	SELL	$27.7 - $31.39 $5,955 - $6,748	-215 Reduced 1.96%	10,780 $311,000
Q2 2024 Aug 02, 2024	BUY	$25.26 - $29.6 $75,729 - $88,740	2,998 Added 37.49%	10,995 $307,000
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $18,071 - $20,751	698 Added 9.56%	7,997 $221,000
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $2,194 - $2,850	-84 Reduced 1.14%	7,299 $210,000
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $256,256 - $332,849	-9,807 Reduced 57.05%	7,383 $212,000
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $3,497 - $4,088	109 Added 0.64%	17,190 $570,000
Q2 2023 Jul 21, 2023	SELL	$36.12 - $41.79 $113,272 - $131,053	-3,136 Reduced 15.51%	17,081 $626,000
Q1 2023 Apr 24, 2023	BUY	$39.39 - $51.28 $11,226 - $14,614	285 Added 1.43%	20,217 $824,000
Q4 2022 Mar 03, 2023	SELL	$41.75 - $54.5 $5,552 - $7,248	-133 Reduced 0.66%	19,932 $1.02 Million
Q3 2022 Oct 25, 2022	SELL	$43.76 - $53.42 $7,701 - $9,401	-176 Reduced 0.87%	20,065 $878,000
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $35,967 - $42,646	773 Added 3.97%	20,241 $1.06 Million
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $21,548 - $26,700	471 Added 2.48%	19,468 $1.01 Million
Q4 2021 Feb 04, 2022	BUY	$41.32 - $61.25 $5,206 - $7,717	126 Added 0.67%	18,997 $1.01 Million
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $157,628 - $202,486	-4,016 Reduced 17.55%	18,871 $812,000
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $52,141 - $59,067	1,452 Added 6.77%	22,887 $896,000
Q1 2021 Apr 27, 2021	BUY	$33.49 - $37.77 $166,947 - $188,283	4,985 Added 30.3%	21,435 $777,000
Q4 2020 Jan 25, 2021	BUY	$33.47 - $42.56 $20,851 - $26,514	623 Added 3.94%	16,450 $601,000
Q3 2020 Oct 21, 2020	BUY	$31.75 - $37.25 $502,507 - $589,555	15,827 New	15,827 $551,000

Others Institutions Holding PFE

# of Institutions

3,369

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $136B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crumly & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crumly & Associates Inc. with notifications on news.

Account

Crumly & Associates Inc. Pfizer Inc Transaction History